Checkpoint Therapeutics, Inc.

NASDAQ:CKPT

3.21 (USD) • At close January 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 00.04100.0060.0310.0310.0350.0740.0480.0180.0520.0160.0290.1550.0680.0270.0280.0420.9720.0250.281.0510.3523.0310.0050.1270.3430.3320.3490.3510.6930.4980.5461.2490.2770.0650.0254.070.5
Cost of Revenue 04.488.4978.2995.49613.94515.82614.2368.86612.05314.6727.6589.3847.1984.2138.6072.3863.0292.6356.733.8944.124.58113.4217.8485.4536.9324.9164.9555.5063.7047.7434.7135.4462.3657.4431.4142.0352.035
Gross Profit 0-4.439-8.497-8.293-5.465-13.914-15.791-14.162-8.818-12.035-14.618-27.642-9.355-7.043-4.145-8.58-2.358-2.987-1.663-6.705-3.614-3.069-4.229-10.39-7.843-5.326-6.589-4.584-4.606-5.155-3.011-7.245-4.167-4.197-2.088-7.378-1.3892.035-1.535
Gross Profit Ratio 0-108.2680-1,382.167-176.29-448.839-451.171-191.378-183.708-668.611-281.115-1,727.625-322.586-45.439-60.956-317.778-84.214-71.119-1.711-268.2-12.907-2.92-12.014-3.428-1,568.6-41.937-19.21-13.807-13.198-14.687-4.345-14.548-7.632-3.36-7.538-113.508-55.560.5-3.07
Reseach & Development Expenses 6.3664.488.4978.2995.49613.94515.82614.2368.86612.05314.6727.6589.3847.1984.2138.1452.5433.0292.6356.733.8944.124.58113.4217.8485.4536.9324.9164.9555.5063.7047.7434.7135.4462.3655.3593.4850.4442.035
General & Administrative Expenses 3.3582.2342.4511.8762.2362.2812.2922.4821.8462.1292.2432.1281.9232.1142.3732.1242.4291.6871.6782.1521.621.7581.7031.5021.5441.3522.1941.3551.3441.3171.4031.090.9721.2211.1842.1560.2190.0310.082
Selling & Marketing Expenses 000.10.30000.400.200000000000000000000000000000
SG&A 3.3582.2342.4511.8762.2362.2812.2922.4821.8462.1292.2432.1281.9232.1142.3732.1242.4291.6871.6782.1521.621.7581.7031.5021.5441.3522.1941.3551.3441.3171.4031.090.9721.2211.1842.1560.2190.0310.082
Other Expenses 000000000000000000000000000000000000000
Operating Expenses 9.7246.71410.94810.1757.73216.22618.11816.71810.71214.18216.91329.78611.3079.3126.58610.2694.9724.7164.3138.8825.5145.8786.28414.9239.3926.8059.1266.2716.2996.8235.1078.8335.6856.6673.5497.5153.7042.510.082
Operating Income -9.724-6.673-10.948-10.169-7.701-16.195-18.083-16.644-10.664-14.164-16.835-29.77-11.278-9.157-6.518-10.242-4.944-4.674-3.341-8.857-5.234-4.827-5.932-11.892-9.387-6.678-8.783-5.939-5.95-6.472-4.414-8.335-5.139-5.418-3.272-7.45-3.679-0.475-1.617
Operating Income Ratio 0-162.7560-1,694.833-248.419-522.419-516.657-224.919-222.167-786.889-323.75-1,860.625-388.897-59.077-95.853-379.333-176.571-111.286-3.437-354.28-18.693-4.593-16.852-3.923-1,877.4-52.583-25.606-17.889-17.049-18.439-6.369-16.737-9.412-4.338-11.812-114.615-147.16-0.117-3.234
Total Other Income Expenses Net -0.0010.0030.003-8.9591.977-0.3267.609-4.3780.0520.0220.0130.0140.0130.0130.0130.0170.0140.0290.060.0310.0280.0350.0420.2730.0430.0390.0180.0210.0220.0240.0310.0120.0110.013-0.333-0.601-0.0700
Income Before Tax -9.725-6.67-10.945-19.128-5.724-16.521-10.474-21.022-10.612-14.142-16.848-29.756-11.265-9.144-6.505-10.225-4.93-4.645-3.281-8.826-5.206-4.792-5.89-11.619-9.344-6.639-8.765-5.918-5.928-6.448-4.383-8.323-5.128-5.405-3.605-8.051-3.749-0.475-1.617
Income Before Tax Ratio 0-162.6830-3,188-184.645-532.935-299.257-284.081-221.083-785.667-324-1,859.75-388.448-58.994-95.662-378.704-176.071-110.595-3.376-353.04-18.593-4.559-16.733-3.833-1,868.8-52.276-25.554-17.825-16.986-18.37-6.325-16.713-9.392-4.327-13.014-123.862-149.96-0.117-3.234
Income Tax Expense 00-0.04315.341-7.701-0.031-7.6094.343-0.104-0.044-0.026-0.014-0.054-0.056-0.055-0.055-0.053-0.051-0.047-0.046-0.045-0.041-5.932-11.892-9.387-6.678-8.78300000-5.139000-3.67900
Net Income -9.725-6.67-10.945-19.128-5.724-16.521-2.865-25.365-10.508-14.098-16.822-29.756-11.265-9.144-6.505-10.225-4.93-4.645-3.281-8.826-5.206-4.792-5.89-11.619-9.344-6.639-8.765-5.918-5.928-6.448-4.383-8.323-5.128-5.405-3.605-8.051-3.749-0.475-1.617
Net Income Ratio 0-162.6830-3,188-184.645-532.935-81.857-342.77-218.917-783.222-323.5-1,859.75-388.448-58.994-95.662-378.704-176.071-110.595-3.376-353.04-18.593-4.559-16.733-3.833-1,868.8-52.276-25.554-17.825-16.986-18.37-6.325-16.713-9.392-4.327-13.014-123.862-149.96-0.117-3.234
EPS -0.23-0.18-0.33-0.7-0.29-1.05-0.24-2.47-1.19-1.61-1.98-3.79-1.43-1.21-0.93-1.81-0.87-0.9-0.64-1.73-1.51-1.47-1.83-3.73-3.19-2.29-3.54-2.39-2.6-2.84-1.99-3.81-2.1-2.21-1.48-3.3-1.53-0.57-2.02
EPS Diluted -0.23-0.18-0.33-0.7-0.29-1.05-0.24-2.47-1.19-1.61-1.98-3.79-1.43-1.21-0.93-1.81-0.87-0.9-0.64-1.73-1.51-1.47-1.83-3.6-3.19-2.29-3.54-2.39-2.6-2.84-1.99-3.77-2.1-2.21-1.48-3.3-1.53-0.57-2.02
EBITDA -9.724-6.673-10.948-10.169-7.701-16.195-18.083-16.644-10.664-14.164-16.861-29.77-11.278-9.157-6.518-10.242-4.944-4.674-3.341-8.857-5.234-4.827-5.932-11.892-9.387-6.678-8.783-5.918-5.928-6.448-4.383-8.323-5.128-5.405-3.261-7.886000
EBITDA Ratio 0-162.7560-1,694.833-248.419-510.903-732.829-224.919-222.167-786.889-324.25-1,860.625-388.897-59.077-95.853-379.333-176.571-111.286-3.437-354.28-18.693-4.593-16.852-3.923-1,877.4-52.583-25.606-17.825-16.986-18.37-6.325-16.713-9.412-4.327-11.773-121.323-147.1600